Tokyo Tape
Sign in
← PHC Holdings

Quarterly report · Q1

6523.TEDINET S100OZNU
Period2022-04-01 → 2022-06-30
Filed2022-08-10
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥81.5bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Revenue¥340.5bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥80.9bn2021-04-01 → 2021-06-30Cons.Revenue IFRS
Operating income¥2.0bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Operating income¥5.6bn2021-04-01 → 2021-06-30Cons.Operating profit loss IFRS
Profit before tax−¥6.3bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Profit before tax¥3.0bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥14.1bn2021-04-01 → 2021-06-30Cons.Profit loss before tax IFRS
Net income (owners)−¥7.1bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥8.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥10.4bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income−¥7.0bn2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Net income¥10.4bn2021-04-01 → 2021-06-30Cons.Profit loss IFRS
Total assets¥595.7bnat 2022-06-30Cons.Assets IFRS
Total assets¥591.3bnat 2022-03-31Cons.Assets IFRS
Total assets¥571.4bnat 2021-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥458.0bnat 2022-06-30Cons.Liabilities IFRS
Total liabilities¥455.3bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥137.7bnat 2022-06-30Cons.Equity IFRS
Net assets / equity¥136.1bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥119.6bnat 2021-06-30Cons.Equity IFRS
Net assets / equity¥107.6bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥136.9bnat 2022-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥135.4bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥119.0bnat 2021-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥82.1bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥95.2bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥57.5bnat 2021-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥60.8bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥1.9bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥51.1bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥13.8bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥5.2bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥12.5bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥4.7bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥11.9bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥7.0bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥13.0bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-57.262022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-70.782021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥89.392021-04-01 → 2021-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥-57.262022-04-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-70.782021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥86.312021-04-01 → 2021-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio23.0%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio22.9%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio20.8%at 2021-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30¥552m
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-06-30¥552m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥6.7bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue2022-04-01 → 2022-06-30¥26.5bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue external2022-04-01 → 2022-06-30¥26.5bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentsegment profit2022-04-01 → 2022-06-30¥5.5bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2022-04-01 → 2022-06-30¥23.4bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2022-04-01 → 2022-06-30¥23.4bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.2bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue2022-04-01 → 2022-06-30¥31.1bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue external2022-04-01 → 2022-06-30¥31.1bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.0bn
—segment totalrevenue2022-04-01 → 2022-06-30¥80.9bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥80.9bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥8.8bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30¥940m
Reconciling Itemsreconcilingrevenue external2021-04-01 → 2021-06-30¥940m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥3.1bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue2021-04-01 → 2021-06-30¥26.3bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue external2021-04-01 → 2021-06-30¥26.3bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentsegment profit2021-04-01 → 2021-06-30¥3.5bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2021-04-01 → 2021-06-30¥21.9bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2021-04-01 → 2021-06-30¥21.9bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2021-04-01 → 2021-06-30¥1.7bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue2021-04-01 → 2021-06-30¥31.8bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue external2021-04-01 → 2021-06-30¥31.8bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentsegment profit2021-04-01 → 2021-06-30¥3.6bn
—segment totalrevenue2021-04-01 → 2021-06-30¥80.0bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥80.0bn
—segment totalsegment profit2021-04-01 → 2021-06-30¥8.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 810
ItemContextValueUnit
Other ss IFRSCurrentYTDDuration_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember－JPY
Other ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Other ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember－JPY
Other ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-13000000JPY
Other ss IFRSCurrentYTDDuration-13000000JPY
Total transactions with owners IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Total transactions with owners IFRSCurrentYTDDuration_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember－JPY
Total transactions with owners IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-1182000000JPY
Total transactions with owners IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-4459000000JPY
Total transactions with owners IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-13000000JPY
Total transactions with owners IFRSCurrentYTDDuration-4472000000JPY
Equity IFRSCurrentQuarterInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember27172000000JPY
Equity IFRSCurrentQuarterInstant_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember640000000JPY
Equity IFRSCurrentQuarterInstant_OtherComponentsOfEquityIFRSMember28278000000JPY
Equity IFRSCurrentQuarterInstant_EquityAttributableToOwnersOfParentIFRSMember136863000000JPY
Equity IFRSCurrentQuarterInstant_NonControllingInterestsIFRSMember818000000JPY
Equity IFRSCurrentQuarterInstant137681000000JPY
Profit loss before tax IFRSPrior1YTDDuration14112000000JPY
Profit loss before tax IFRSCurrentYTDDuration-6297000000JPY
Depreciation expense ope cf IFRSPrior1YTDDuration7831000000JPY
Depreciation expense ope cf IFRSCurrentYTDDuration7446000000JPY
Impairment losses reversal of impairment losses ope cf IFRSPrior1YTDDuration5000000JPY
Impairment losses reversal of impairment losses ope cf IFRSCurrentYTDDuration74000000JPY
Gain loss from financial assets measured at fair value through profit or loss ope cf IFRSPrior1YTDDuration-10612000000JPY
Gain loss from financial assets measured at fair value through profit or loss ope cf IFRSCurrentYTDDuration6127000000JPY
Interest expenses ope cf IFRSPrior1YTDDuration1503000000JPY
Interest expenses ope cf IFRSCurrentYTDDuration1024000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSPrior1YTDDuration17000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSCurrentYTDDuration125000000JPY
Loss gain on sale of fixed assets ope cf IFRSPrior1YTDDuration-13000000JPY
Loss gain on sale of fixed assets ope cf IFRSCurrentYTDDuration-1000000JPY
Decrease increase in trade receivables ope cf IFRSPrior1YTDDuration4917000000JPY
Decrease increase in trade receivables ope cf IFRSCurrentYTDDuration7171000000JPY
Decrease increase in inventories ope cf IFRSPrior1YTDDuration-1917000000JPY
Decrease increase in inventories ope cf IFRSCurrentYTDDuration-1540000000JPY
Increase decrease in trade payables ope cf IFRSPrior1YTDDuration-2835000000JPY
Increase decrease in trade payables ope cf IFRSCurrentYTDDuration-5961000000JPY
Increase decrease in retirement benefit liability ope cf IFRSPrior1YTDDuration-146000000JPY
Increase decrease in retirement benefit liability ope cf IFRSCurrentYTDDuration11000000JPY
Other changes in working capital ope cf IFRSPrior1YTDDuration4782000000JPY
Other changes in working capital ope cf IFRSCurrentYTDDuration-3561000000JPY
Subtotal ope cf IFRSPrior1YTDDuration17645000000JPY
Subtotal ope cf IFRSCurrentYTDDuration4618000000JPY
Interest and dividends received ope cf IFRSPrior1YTDDuration321000000JPY
Interest and dividends received ope cf IFRSCurrentYTDDuration263000000JPY
Interest paid ope cf IFRSPrior1YTDDuration-967000000JPY
Interest paid ope cf IFRSCurrentYTDDuration-829000000JPY
Income taxes paid ope cf IFRSPrior1YTDDuration-3214000000JPY
Income taxes paid ope cf IFRSCurrentYTDDuration-2388000000JPY
Income taxes refund ope cf IFRSPrior1YTDDuration3000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass